🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Estee Lauder's Have & Be Buyout To Boost Skin Care Unit

Published 12/17/2019, 09:13 PM
Updated 07/09/2023, 06:31 AM
EL
-
PG
-
LFCR
-

The Estee Lauder Companies Inc. (NYSE:EL) concluded the acquisition of two-thirds shares of Have & Be Co. — the Seoul-based skin care company — which owns brands like Dr. Jart+ and Do The Right Thing. In 2015, Estee Lauder had made a minor investment in Have & Be.

The company initially announced the acquisition of the remaining two-thirds shares in November. Management had stated that Have & Be had an enterprise value of $1.7 billion. Also, the company had earlier announced to fund this transaction with debt.

Have & Be Acquisition Holds Promise

Launched in 2005, Dr. Jart+ — Have & Be’s skin care brand — focuses on making high-quality products that combine dermatology, art and innovation. Cicapair and Ceramidin are some of the best known skin care collections of the brand. Dr Jart+ offers a broad range of exclusive moisturizers, masks, cleansers and serums, which are sold through specialty-multi channels, travel retail, freestanding stores, high-end department stores and online websites in over 35 countries worldwide.

Notably, Dr. Jart+ has become one of the most popular Korean skin care brands globally, especially among millennials in Asia and the United States. This fast growing brand is expected to help Estee Lauder strengthen its skin care business and expand operations in Asia/Pacific, North America, the U.K. as well as the travel retail network.

Well, Estee Lauder is witnessing rapid growth in its skin care segment driven by focus on innovation along with prudent marketing and advertising strategies in this category. Notably, skin care reported sales growth of 24% year over year (up 25% at cc) in the last reported quarter, backed by strength in Estee Lauder and La Mer brands.

We believe that, Estee Lauder’s strong focus on enhancing brand portfolio through strategic partnerships will expand customer base and propel innovation in the skin care market.

Notably, this Zacks Rank #3 (Hold) stock has increased 12.6% in the past six months compared with the industry’s rise of 8.8%.



Top Picks

e.l.f. Beauty, Inc (NYSE:EL) , with a Zacks Rank #2 (Buy), has a long-term earnings per share (EPS) growth rate of 3.8%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Procter & Gamble Company (NYSE:PG) , with a Zacks Rank #2, has a long-term EPS growth rate of 7.5%.

Landec Corporation (NASDAQ:LNDC) , with a Zacks Rank #2, has a long-term EPS growth rate of 10%.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.6% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>



Landec Corporation (LNDC): Free Stock Analysis Report

The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

e.l.f. Beauty Inc. (ELF): Free Stock Analysis Report

Procter & Gamble Company (The) (PG): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.